CytomX TherapeuticsCTMX
那斯達克 · USD
4.06
+0.16
(+4.10%)
收盤 12/12 04:59 (UTC+8)
12/12 04:59 (UTC+8)
CytomX TherapeuticsCTMX
4.06
+0.16
(+4.10%)
財務數據
損益表
- 0.25
- 0.26
- 0.27
- 0.41
- 0.25
- 0.33
- 0.38
- 0.51
- 0.19
- 0.06
- 5.21
- 6.71
- 0.85
- 55.83
- -39.43
- 33.12
- 13.94
- 33.66
- -63.36
- -68.04
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 5,963 | 18,658 | 50,917 | 38,093 | 33,432 | 25,115 | 41,463 | 26,607 | 26,384 | 24,724 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 5,963 | 18,658 | 50,917 | 38,093 | 33,432 | 25,115 | 41,463 | 26,607 | 26,384 | 24,724 |
營業費用 | 21,731 | 19,943 | - | - | - | - | - | 27,213 | 23,261 | 28,072 |
研發費用 | 15,304 | 13,321 | 18,868 | 14,790 | 21,368 | 25,172 | 22,052 | 19,386 | 16,448 | 20,671 |
推銷及管理費用 | 6,427 | 6,622 | 9,428 | 5,624 | 7,953 | 8,395 | 7,754 | 7,827 | 6,813 | 7,401 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -15,768 | -1,285 | 22,621 | 17,679 | 4,111 | -8,452 | 11,657 | -606 | 3,123 | -3,348 |
其他收入及費用 | 1,597 | 1,195 | 966 | 1,259 | 1,686 | 1,970 | 2,183 | 2,512 | 2,692 | 2,261 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -14,171 | -90 | 23,587 | 18,938 | 5,797 | -6,482 | 13,840 | 1,906 | 5,815 | -1,087 |
所得稅 | 58 | 64 | 62 | 62 | 61 | 52 | 49 | 1,069 | 2,823 | - |
稅後純益 | -14,229 | -154 | 23,525 | 18,876 | 5,736 | -6,534 | 13,791 | 837 | 2,992 | -1,087 |
基本每股稅後盈餘(元) | -0.09 | 0.00 | 0.27 | 0.22 | 0.07 | -0.08 | 0.17 | - | 0.04 | -0.02 |
稀釋每股稅後盈餘(元) | -0.14 | -0.06 | 0.27 | 0.23 | 0.06 | -0.08 | 0.17 | 0.01 | 0.05 | -0.02 |
基本平均股數(千股) | 165004.00 | 129075.00 | 87121.00 | 85755.00 | 85093.00 | 84880.00 | 82029.00 | - | 80731.00 | 66536.00 |
稀釋平均股數(千股) | 165004.00 | 129075.00 | 87150.00 | 86266.00 | 85204.00 | 84880.00 | 82630.00 | - | 80991.00 | 66536.00 |
還原基本每股稅後盈餘(元) | -0.09 | 0.00 | 0.27 | 0.22 | 0.07 | -0.08 | 0.17 | - | 0.04 | -0.02 |
還原稀釋每股稅後盈餘(元) | -0.14 | -0.06 | 0.27 | 0.23 | 0.06 | -0.08 | 0.17 | 0.01 | 0.05 | -0.02 |
還原基本平均股數(千股) | 165,004 | 129,075 | 87,121 | 85,755 | 85,093 | 84,880 | 82,029 | - | 80,731 | 66,536 |
還原稀釋平均股數(千股) | 165,004 | 129,075 | 87,150 | 86,266 | 85,204 | 84,880 | 82,630 | - | 80,991 | 66,536 |
EBITDA(千元) | -14,673 | -140 | 23,518 | 18,564 | 5,006 | -7,461 | 12,441 | 166 | 4,366 | -2,202 |